Lucid Diagnostics Inc. logo

Lucid Diagnostics Inc.

NASDAQ:LUCD

Overview | Financials
Company Name Lucid Diagnostics Inc.
Symbol LUCD
Currency USD
Price 0.832
Market Cap 44,914,526
Dividend Yield 0%
52-week-range 0.63 - 1.58
Industry Medical Devices
Sector Healthcare
CEO Dr. Lishan Aklog M.D.
Website https://www.luciddx.com

An error occurred while fetching data.

About Lucid Diagnostics Inc.

Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company. The company focuses on patients with gastroesophageal reflux disease, which is also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. Its lead products

Related Stocks

Cytosorbents Corporation logo

Cytosorbents Corporation

CTSO

1.42 USD

Tabula Rasa HealthCare, Inc. logo

Tabula Rasa HealthCare, Inc.

TRHC

10.5 USD

Xilio Therapeutics, Inc. logo

Xilio Therapeutics, Inc.

XLO

0.815 USD

Adverum Biotechnologies, Inc. logo

Adverum Biotechnologies, Inc.

ADVM

6.99 USD

Capricor Therapeutics, Inc. logo

Capricor Therapeutics, Inc.

CAPR

5.12 USD

Alzamend Neuro, Inc. logo

Alzamend Neuro, Inc.

ALZN

1.73 USD

HOOKIPA Pharma Inc. logo

HOOKIPA Pharma Inc.

HOOK

4.62 USD

Puma Biotechnology, Inc. logo

Puma Biotechnology, Inc.

PBYI

2.5 USD

Financials

Numbers are in millions USD

Numbers are in millions USD